As on Wednesday, Replimune Group Inc (NASDAQ: REPL) got off with the flyer as it spiked 0.33% to $12.01, before settling in for the price of $11.97 at the close. Taking a more long-term approach, REPL posted a 52-week range of $4.92-$15.18.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 0.00% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -19.52%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 3.38%. This publicly-traded company’s shares outstanding now amounts to $61.42 million, simultaneously with a float of $52.46 million. The organization now has a market capitalization sitting at $820.52 million. At the time of writing, stock’s 50-day Moving Average stood at $10.90, while the 200-day Moving Average is $8.71.
Replimune Group Inc (REPL) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Replimune Group Inc’s current insider ownership accounts for 23.22%, in contrast to 87.96% institutional ownership. According to the most recent insider trade that took place on Aug 16 ’24, this organization’s Chief Financial Officer sold 8,938 shares at the rate of 10.18, making the entire transaction reach 90,989 in total value, affecting insider ownership by 101,057. Preceding that transaction, on Jun 07 ’24, Company’s Chief Medical Officer sold 15,881 for 7.50, making the whole transaction’s value amount to 119,108. This particular insider is now the holder of 117,131 in total.
Replimune Group Inc (REPL) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.78 per share during the current fiscal year.
Replimune Group Inc’s EPS increase for this current 12-month fiscal period is 3.38% and is forecasted to reach -2.62 in the upcoming year.
Replimune Group Inc (NASDAQ: REPL) Trading Performance Indicators
Let’s observe the current performance indicators for Replimune Group Inc (REPL). It’s Quick Ratio in the last reported quarter now stands at 13.46. The Stock has managed to achieve an average true range (ATR) of 0.67.
In the same vein, REPL’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.34, a figure that is expected to reach -0.82 in the next quarter, and analysts are predicting that it will be -2.62 at the market close of one year from today.
Technical Analysis of Replimune Group Inc (REPL)
Through scrutinizing the latest numbers posted by the [Replimune Group Inc, REPL], it can be observed that its last 5-days Average volume of 0.45 million was lower the volume of 1.08 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 83.22% While, its Average True Range was 0.66.
Raw Stochastic average of Replimune Group Inc (REPL) in the period of the previous 100 days is set at 89.28%, which indicates a major rise in contrast to 85.54% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 62.08% that was lower than 80.29% volatility it exhibited in the past 100-days period.
